Potassium canrenoate

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Aldosterone antagonist.

Half-lifeThis section has been translated automatically.

10–18 h

IndicationThis section has been translated automatically.

Edema.

Dosage and method of useThis section has been translated automatically.

2-4 times 0.1 g/day p.o. over 3-6 days; long-term therapy: 0.1 g/day or every 2 days p.o.

Note! Check serum potassium level regularly!

Undesirable effectsThis section has been translated automatically.

Hyperkalemia, impotence, voice changes.

InteractionsThis section has been translated automatically.

Acetylsalicylic acid reduces the effect, potassium-sparing diuretics increase potassium-saving effect.

ContraindicationThis section has been translated automatically.

Hyperkalemia and -natremia, reduced renal function.

PreparationsThis section has been translated automatically.

Aldactone 10 ml, potassium can. ratiopharm

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer